MedTrace Logo

Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007

NCT01183377 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2010-08-17

No results posted yet for this study

Summary

Women's evermore presence in professional and athletic sports has revealed sound evidence on the existence of female athlete triad among the world's elite female athletes. This triad consists of eating disorders, amenorrhea and osteoporosis. It has been stated that all female athletes are potentially at risk, but it is not clear to what extent those exercising at different levels are at risk of this syndrome/triad. Since the manifestation of this triad is often denied, or under-reported, appropriate screening methods are required to identify the symptoms. There is still no clear-cut information available on the incidence of this triad in Iran. And there are religious and cultural differences between Iran's elite female athletes and those in other countries. Therefore, in order to meet Iranian female athletes' needs, the investigators decided to determine the frequency of the female athlete triad in Iran.

Conditions

  • Menstruation Disturbances
  • Eating Disorder
  • Bone Loss

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Haleh Dadgostar, MD · Rheumatology Research Center, Tehran University for Medical Sciences

  • Fereydoun Davatchi, MD · Rheumatology Research Center, Tehran University for Medical Sciences

  • Shafie Movaseghi, MD · Rheumatology Research Center, Tehran University for Medical Sciences

  • ashraf Aleyasin, MD · Tehran University for Medical Sciences

  • mohamad hosein Forozanfar, MD · Rheumatology Research Center, Tehran University for Medical Sciences

  • Talia Alenabi, MD · Sport Medicine Federation of Islamic Republic Of Iran

  • Narges Chime, MD · Shahid Beheshti University of Medical Sciences

  • pooneh Kimia ghalam, MD · Health ministry of Iran

Eligibility

Min Age
13 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01183377 on ClinicalTrials.gov